Submission Details
| 510(k) Number | K232216 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 26, 2023 |
| Decision Date | April 19, 2024 |
| Days to Decision | 268 days |
| Submission Type | Traditional |
| Review Panel | General & Plastic Surgery (SU) |
| Summary | Summary PDF |
K232216 is an FDA 510(k) clearance for the Hemoblock_S (Prescription); Hemoblock_S (OTC), a Hemostatic Wound Dressing Without Thrombin Or Other Biologics, submitted by Incore Co., Ltd. (Daegu, KR). The FDA issued a Cleared decision on April 19, 2024, 268 days after receiving the submission on July 26, 2023. This device falls under the General & Plastic Surgery review panel.
| 510(k) Number | K232216 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 26, 2023 |
| Decision Date | April 19, 2024 |
| Days to Decision | 268 days |
| Submission Type | Traditional |
| Review Panel | General & Plastic Surgery (SU) |
| Summary | Summary PDF |
| Product Code | QSY — Hemostatic Wound Dressing Without Thrombin Or Other Biologics |
| Device Class | — |
| Definition | To Temporarily Control Bleeding And Cover External Wounds. |